Skip to main content
Donate

Families & Caregivers

Communication

The Everything-About-Angelman Handout

For you, your friends and family, schools, doctors and therapists—whomever in your life needs to know about AS and treating it. To get a digital PDF emailed or physical copies sent to you, click the GIF below.

The Everything-About-Angelman Handout image

Communication comes in all forms for individuals who live with Angelman syndrome. Each individual navigates this in their own way. Here are some resources for guidance.

Angelman Syndrome News

Ultragenyx Announces First Patient(s) Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angel...

FAST Spain Awards First Research Grant

FAST and ASF Advocate for Crucial Legislation

CAN Spotlight: 2nd Annual Hole Out Fore Heath Golf Tournament

CAN Spotlight: Paddle Party for a Purpose

FAST and ASF Announce their Partnership with the Institute for Gene Therapies

RSVP for the January 2025 EL-PFDD Meeting

2024 Global Science Summit Recap

Ionis Pharmaceuticals releases information on their planned phase 3 clinical trial for Angelman syndrome

CAN Spotlight: Remi Cup 2024

The PFDD Survey is now open

Watch the Clinical Trials 101 Video

Watch the ASF | FAST Ultragenyx Community Webinar recording

CAN Spotlight: Bike for Briar’s MEGA Meat Raffle

FAST UK hosts Art for Angelman 2024

CAN Spotlight: All in for Olin Fundraiser

CAN Spotlight: Friends of James Oktoberfest

Ultragenyx Community Update October 2024

CAN Spotlight: Maddie's Mission 3rd Annual Block Party Tailgate

CAN Spotlight: 100 mile Coast to Coast Triathlon for Angelman Syndrome

Ultragenyx Announces First Patient(s) Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angel...

FAST Spain Awards First Research Grant

FAST and ASF Advocate for Crucial Legislation

CAN Spotlight: 2nd Annual Hole Out Fore Heath Golf Tournament

CAN Spotlight: Paddle Party for a Purpose

FAST and ASF Announce their Partnership with the Institute for Gene Therapies

RSVP for the January 2025 EL-PFDD Meeting

2024 Global Science Summit Recap

Ionis Pharmaceuticals releases information on their planned phase 3 clinical trial for Angelman syndrome

CAN Spotlight: Remi Cup 2024

The PFDD Survey is now open

Watch the Clinical Trials 101 Video

Watch the ASF | FAST Ultragenyx Community Webinar recording

CAN Spotlight: Bike for Briar’s MEGA Meat Raffle

FAST UK hosts Art for Angelman 2024

CAN Spotlight: All in for Olin Fundraiser

CAN Spotlight: Friends of James Oktoberfest

Ultragenyx Community Update October 2024

CAN Spotlight: Maddie's Mission 3rd Annual Block Party Tailgate

CAN Spotlight: 100 mile Coast to Coast Triathlon for Angelman Syndrome

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.